Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7376)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2013 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8168.htm |
| Number | Citing Articles |
| 1 |
Ghadeer Turki Aloutaibi, Abdulrahman L. Al-Malki, Maha J. Balgoon, Saud A. Bahaidarah, Said Salama Moselhy. Rheumatic Heart Disease and Its Association with H. pylori Infection. Journal of Pure and Applied Microbiology 2021; 15(2): 580 doi: 10.22207/JPAM.15.2.42
|
| 2 |
Binjie Hu, Fuju Zhao, Shiwen Wang, Michal A Olszewski, Haipeng Bian, Yong Wu, Mimi Kong, Lingli Xu, Yingxin Miao, Yi Fang, Changqing Yang, Hu Zhao, Yanmei Zhang.
A High-Throughput Multiplex Genetic Detection System for
Helicobacter Pylori
Identification, Virulence and Resistance Analysis
. Future Microbiology 2016; 11(10): 1261 doi: 10.2217/fmb-2016-0023
|
| 3 |
G. Losurdo, A. Iannone, F. Giorgio, M. Principi, A. Di Leo, E. Ierardi. Letter: could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment?. Alimentary Pharmacology & Therapeutics 2016; 43(7): 844 doi: 10.1111/apt.13544
|
| 4 |
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events. United European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
|
| 5 |
Enzo Ierardi, Giuseppe Losurdo, Alessia Mileti, Rosa Paolillo, Floriana Giorgio, Mariabeatrice Principi, Alfredo Di Leo. The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science. Antibiotics 2020; 9(6): 293 doi: 10.3390/antibiotics9060293
|
| 6 |
Ahmed Hossain, Saeem Arafat Hossain, Aneeka Nawar Fatema, Abrar Wahab, Mohammad Morshad Alam, Md. Nazrul Islam, Mohammad Zakir Hossain, Gias U. Ahsan. Age and gender-specific antibiotic resistance patterns among Bangladeshi patients with urinary tract infection caused by Escherichia coli. Heliyon 2020; 6(6): e04161 doi: 10.1016/j.heliyon.2020.e04161
|
| 7 |
Sinéad M Smith, Colm O’Morain, Deirdre McNamara. Antimicrobial susceptibility testing for <italic>Helicobacter pylori</italic> in times of increasing antibiotic resistance. World Journal of Gastroenterology 2014; 20(29): 9912-9921 doi: 10.3748/wjg.v20.i29.9912
|
| 8 |
Ali Baradaran Moghaddam, Nour Amirmozafari, Shahla Mansouri, Nastaran Farzi, Naser Ebrahimi-Daryani, Masoud Alebouyeh, Mohammad Reza Zali. Nitazoxanide and Doxycycline Sensitivity Among Metronidazole Resistant Helicobacter pylori Isolates from Patients with Gastritis. Archives of Clinical Infectious Diseases 2018; 13(1) doi: 10.5812/archcid.66693
|
| 9 |
Priscila Baptistella Yazbek, Ariane Biolcati Trindade, Chung Man Chin, Jean Leandro dos Santos. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori. Digestive Diseases and Sciences 2015; 60(10): 2901 doi: 10.1007/s10620-015-3712-y
|
| 10 |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLOS ONE 2016; 11(12): e0166199 doi: 10.1371/journal.pone.0166199
|
| 11 |
Aldona Bińkowska, Monika Maria Biernat, Łukasz Łaczmański, Grażyna Gościniak. Molecular Patterns of Resistance Among Helicobacter pylori Strains in South-Western Poland. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.03154
|
| 12 |
Nastaran Farzi, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Sinéad Marian Smith, Josette Raymond, Hidekazu Suzuki, Mohammad Reza Zali. High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping. Journal of Clinical Medicine 2019; 8(11): 2004 doi: 10.3390/jcm8112004
|
| 13 |
Abu Iftiaf Md Salah Ud-Din, Anna Roujeinikova. Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics. Cellular and Molecular Life Sciences 2018; 75(7): 1163 doi: 10.1007/s00018-017-2696-5
|
| 14 |
Sukdong Lee, Gregory T. Sneed, Jamie N. Brown. Treatment of Helicobacter pylori with nitazoxanide-containing regimens: a systematic review. Infectious Diseases 2020; 52(6): 381 doi: 10.1080/23744235.2019.1708454
|
| 15 |
CA Chew, TF Lye, D Ang, TL Ang. The diagnosis and management of H. pylori infection in Singapore. Singapore Medical Journal 2017; 58(5): 234 doi: 10.11622/smedj.2017037
|
| 16 |
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research. 2016; : 519 doi: 10.1007/978-4-431-55936-8_23
|
| 17 |
Breno Bittencourt de Brito, Filipe Antônio França da Silva, Aline Silva Soares, Vinícius Afonso Pereira, Maria Luísa Cordeiro Santos, Mariana Miranda Sampaio, Pedro Henrique Moreira Neves, Fabrício Freire de Melo. Pathogenesis and clinical management of <i>Helicobacter pylori</i> gastric infection. World Journal of Gastroenterology 2019; 25(37): 5578-5589 doi: 10.3748/wjg.v25.i37.5578
|
| 18 |
Enzo Ierardi, Floriana Giorgio, Giuseppe Losurdo, Claudia Sorrentino, Mariabeatrice Principi, Alfredo Di Leo. Detection of Helicobacter pylori DNA sequences in gastric biopsy samples to refine the diagnosis and therapy.
Journal of Medical Microbiology
2015; 64(7): 788 doi: 10.1099/jmm.0.000075
|
| 19 |
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo. Sequential vs. prolonged 14-day triple therapy forHelicobacter pylorieradication: the meta-analysis may be influenced by ‘geographical weighting’. International Journal of Clinical Practice 2015; 69(10): 1112 doi: 10.1111/ijcp.12687
|
| 20 |
Muhammad Miftahussurur, Pradeep Krishna Shrestha, Phawinee Subsomwong, Rabi Prakash Sharma, Yoshio Yamaoka. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiology 2016; 16(1) doi: 10.1186/s12866-016-0873-6
|
| 21 |
Jun-Won Chung, Jae Pil Han, Kyoung Oh Kim, Su Young Kim, Su Jin Hong, Tae Ho Kim, Chang Whan Kim, Joon Sung Kim, Byung-Wook Kim, Byoung Wook Bang, Hyung Gil Kim, Sung-Cheol Yun. Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. Digestive and Liver Disease 2016; 48(8): 888 doi: 10.1016/j.dld.2016.05.005
|
| 22 |
Giuseppe Losurdo, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Brescia, Maria Rendina, Enzo Ierardi, Alfredo Di Leo. Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. Antibiotics 2022; 11(1): 78 doi: 10.3390/antibiotics11010078
|
| 23 |
R. Ntagirabiri, S. Harerimana, F. Makuraza, E. Ndirahisha, H. Kaze, A. Moibeni. Helicobacter pylori au Burundi : première évaluation de la prévalence en endoscopie et de l’éradication. Journal Africain d'Hépato-Gastroentérologie 2014; 8(4): 217 doi: 10.1007/s12157-014-0567-3
|
| 24 |
I-Ting Wu, Seng-Kee Chuah, Chen-Hsiang Lee, Chih-Ming Liang, Lung-Sheng Lu, Yuan-Hung Kuo, Yi-Hao Yen, Ming-Luen Hu, Yeh-Pin Chou, Shih-Cheng Yang, Chung-Mou Kuo, Chung-Huang Kuo, Chun-Chih Chien, Yu-Shao Chiang, Shue-Shian Chiou, Tsung-Hui Hu, Wei-Chen Tai. Five-year sequential changes in secondary antibiotic resistance of <italic>Helicobacter pylori</italic> in Taiwan. World Journal of Gastroenterology 2015; 21(37): 10669-10674 doi: 10.3748/wjg.v21.i37.10669
|
| 25 |
Elvire Berthenet, Koji Yahara, Kaisa Thorell, Ben Pascoe, Guillaume Meric, Jane M. Mikhail, Lars Engstrand, Helena Enroth, Alain Burette, Francis Megraud, Christine Varon, John C Atherton, Sinead Smith, Thomas S. Wilkinson, Matthew D. Hitchings, Daniel Falush, Samuel K. Sheppard. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk. BMC Biology 2018; 16(1) doi: 10.1186/s12915-018-0550-3
|
| 26 |
Traci L Testerman, James Morris. Beyond the stomach: An updated view of <italic>Helicobacter pylori</italic> pathogenesis, diagnosis, and treatment. World Journal of Gastroenterology 2014; 20(36): 12781-12808 doi: 10.3748/wjg.v20.i36.12781
|
| 27 |
Seng-Kee Chuah, Wei-Chen Tai, Chen-Hsiang Lee, Chih-Ming Liang, Tsung-Hui Hu. Quinolone-Containing Therapies in the Eradication ofHelicobacter pylori. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/151543
|
| 28 |
David Y Graham, Ruben Hernaez, Theodore Rokkas. Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy. Gut 2022; 71(3): 643 doi: 10.1136/gutjnl-2021-326170
|
| 29 |
Sinéad Marian Smith. An Update on the Treatment of Helicobacter Pylori Infection. EMJ Gastroenterology 2015; : 101 doi: 10.33590/emjgastroenterol/10310813
|
| 30 |
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
|
| 31 |
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective. Molecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
|
| 32 |
Giuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori Antibiotic Resistance: Stewardship, Tailored Therapies, and Future Perspectives. Gastroenterology 2021; 161(3): 1071 doi: 10.1053/j.gastro.2021.05.045
|
| 33 |
Enrique Rodríguez de Santiago, Carlos Martín de Argila de Prados, Hector Miguel Marcos Prieto, Miguel Ãngel Jorge Turrión, Eva Barreiro Alonso, Alvaro Flores de Miguel, Cristobal de la Coba Ortiz, Carlos Rodríguez Escaja, Gustavo Pérez Álvarez, Carlos Ferre Aracil, Lara Aguilera Castro, Ana García García de Paredes, Antonio Rodríguez Pérez, Agustin Albillos Martínez. Limited effectiveness with a 10‐day bismuth‐containing quadruple therapy (Pylera®) in third‐line recue treatment for Helicobacter pylori infection. A real‐life multicenter study. Helicobacter 2017; 22(5) doi: 10.1111/hel.12423
|
| 34 |
Makan Pourmasoumi, Ameneh Najafgholizadeh, Amir Hadi, Fariborz Mansour-Ghanaei, Farahnaz Joukar. The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysis. Complementary Therapies in Medicine 2019; 43: 36 doi: 10.1016/j.ctim.2019.01.005
|
| 35 |
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insights. World Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
|
| 36 |
Francesca Celiberto, Giuseppe Losurdo, Maria Pricci, Bruna Girardi, Angela Marotti, Alfredo Di Leo, Enzo Ierardi. The State of the Art of Molecular Fecal Investigations for Helicobacter pylori (H. pylori) Antibiotic Resistances. International Journal of Molecular Sciences 2023; 24(5): 4361 doi: 10.3390/ijms24054361
|
| 37 |
Giuseppe Losurdo, Andrea Iannone, Floriana Giorgio, Mariabeatrice Principi, Alfredo Di Leo, Enzo Ierardi. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: how should rifabutin be managed in rescue regimens?. United European Gastroenterology Journal 2016; 4(3): 474 doi: 10.1177/2050640615623697
|
| 38 |
Tiing Leong Ang, Kwong Ming Fock, Daphne Ang, Andrew Boon Eu Kwek, Eng Kiong Teo, Subbiah Dhamodaran. The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15‐Year Study. Helicobacter 2016; 21(4): 261 doi: 10.1111/hel.12291
|
| 39 |
Enzo Ierardi, Giuseppe Losurdo, Rosa Federica La Fortezza, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo. Optimizing proton pump inhibitors in <i>Helicobacter pylori</i> treatment: Old and new tricks to improve effectiveness. World Journal of Gastroenterology 2019; 25(34): 5097-5104 doi: 10.3748/wjg.v25.i34.5097
|
| 40 |
Ying Chen, Siyu Li, Wenbin Li, Yiran Wang, Jihua Shi, Xue Xu, Pan Zhang, Dan Chen, Rui Gang, Qingfeng Luo. Role of MIC levels and 23S rRNA mutation sites to clarithromycin in 14-day clarithromycin bismuth quadruple therapy for Helicobacter pylori eradication: A prospective trial in Beijing. Heliyon 2024; 10(8): e29774 doi: 10.1016/j.heliyon.2024.e29774
|
| 41 |
Mijung Lee, Jin-Young Chung, Ka Yeun Kim, Wooseok Im, Manho Kim. Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model. BMC Microbiology 2020; 20(1) doi: 10.1186/s12866-020-02055-4
|
| 42 |
Ali Bahadori, Tülin Güven Gökmen, Fatih Köksal, Gökhan Tumgor, Mehmet Agin, Ali Sadighi, Mojtaba Ziaee, Leila Rahbarnia. High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disorders. Gene Reports 2021; 24: 101275 doi: 10.1016/j.genrep.2021.101275
|
| 43 |
Sepehr Tirgar Fakheri, Hajar Shokri‐Afra, David Y. Graham, Zohreh Bari, Hafez Fakheri. A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran. Helicobacter 2024; 29(1) doi: 10.1111/hel.13061
|
| 44 |
Enzo Ierardi, Floriana Giorgio, Andrea Iannone, Giuseppe Losurdo, Mariabeatrice Principi, Michele Barone, Antonio Pisani, Alfredo Di Leo. Noninvasive molecular analysis of <i>Helicobacter pylori</i>: Is it time for tailored first-line therapy?. World Journal of Gastroenterology 2017; 23(14): 2453-2458 doi: 10.3748/wjg.v23.i14.2453
|
| 45 |
Lok Ka Lam, Ka Shing Cheung. Towards the Eradication of <i>Helicobacter pylori</i> Infection - Rapid Diagnosis and Precision Treatment [Working Title]. 2024; doi: 10.5772/intechopen.1004378
|
| 46 |
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
|
| 47 |
Daniel Pohl, Peter M Keller, Valentine Bordier, Karoline Wagner. Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencing. World Journal of Gastroenterology 2019; 25(32): 4629-4660 doi: 10.3748/wjg.v25.i32.4629
|
| 48 |
Jin-Eung Kim, Min-Soo Kim, Yeo-Sang Yoon, Myung-Jun Chung, Do-Young Yum. Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection. Journal of Microbiology 2014; 52(11): 955 doi: 10.1007/s12275-014-4355-y
|
| 49 |
Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh, Chul-Hyun Lim. Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication Rates. Journal of Clinical Medicine 2021; 10(15): 3273 doi: 10.3390/jcm10153273
|
| 50 |
Giuseppe Losurdo, Maria Pricci, Margherita De Bellis, Francesca Celiberto, Francesco Russo, Giuseppe Riezzo, Benedetta D'attoma, Andrea Iannone, Maria Rendina, Enzo Ierardi, Alfredo Di Leo. Effect of metronidazole resistance on Helicobacter pylori eradication regimens. Journal of Digestive Diseases 2022; 23(10): 561 doi: 10.1111/1751-2980.13142
|
| 51 |
Giuseppe Losurdo, Rossella Cubisino, Michele Barone, Mariabeatrice Principi, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Probiotic monotherapy and <i>Helicobacter pylori</i> eradication: A systematic review with pooled-data analysis. World Journal of Gastroenterology 2018; 24(1): 139-149 doi: 10.3748/wjg.v24.i1.139
|
| 52 |
Hideki Mori, Hidekazu Suzuki. Reply to letter to the editor: “The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world”. United European Gastroenterology Journal 2016; 4(3): 476 doi: 10.1177/2050640616631477
|
| 53 |
Takahiro Uotani, Muhammad Miftahussurur, Yoshio Yamaoka. Effect of bacterial and host factors onHelicobacter pylorieradication therapy. Expert Opinion on Therapeutic Targets 2015; 19(12): 1637 doi: 10.1517/14728222.2015.1073261
|
| 54 |
Amin Talebi Bezmin Abadi, Enzo Ierardi. Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00316
|
| 55 |
Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong. In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains. Gut and Liver 2017; 11(5): 648 doi: 10.5009/gnl16503
|
| 56 |
Raffaele Licinio, Giuseppe Losurdo, Sonia Carparelli, Andrea Iannone, Floriana Giorgio, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal. Immunopharmacology and Immunotoxicology 2016; 38(6): 408 doi: 10.1080/08923973.2016.1247855
|
| 57 |
Sung Bum Kim, Si Hyung Lee, Kyeong Ok Kim, Byung Ik Jang, Tae Nyeun Kim. Ten-day Sequential TherapyversusBismuth Based Quadruple Therapy as Second Line Treatment forHelicobacter pyloriInfection. The Korean Journal of Gastroenterology 2015; 66(5): 261 doi: 10.4166/kjg.2015.66.5.261
|
| 58 |
I. Thung, H. Aramin, V. Vavinskaya, S. Gupta, J. Y. Park, S. E. Crowe, M. A. Valasek. Review article: the global emergence ofHelicobacter pyloriantibiotic resistance. Alimentary Pharmacology & Therapeutics 2016; 43(4): 514 doi: 10.1111/apt.13497
|
| 59 |
Anil John, Saad Al Kaabi, Sanjay Doiphode, Prem Chandra, Manik Sharma, Ragesh Babu, Rafie Yacoub, Moutaz Derbala. Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?. Indian Journal of Gastroenterology 2015; 34(5): 404 doi: 10.1007/s12664-015-0604-1
|
| 60 |
Floriana Giorgio, Enzo Ierardi, Claudia Sorrentino, Mariabeatrice Principi, Michele Barone, Giuseppe Losurdo, Andrea Iannone, Antonio Giangaspero, Rosa Monno, Alfredo Di Leo. Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. Scandinavian Journal of Gastroenterology 2016; 51(12): 1429 doi: 10.1080/00365521.2016.1216592
|
| 61 |
Skander Hathroubi, Stephanie L. Servetas, Ian Windham, D. Scott Merrell, Karen M. Ottemann. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Microbiology and Molecular Biology Reviews 2018; 82(2) doi: 10.1128/MMBR.00001-18
|
| 62 |
Fatemeh Forooghi Nia, Atefe Rahmati, Mona Ariamanesh, Jafar Saeidi, Ahmad Ghasemi, Mahnaz Mohtashami. The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice. World Journal of Microbiology and Biotechnology 2023; 39(5) doi: 10.1007/s11274-023-03555-x
|
| 63 |
Paolo Ruggiero, Stefano Censini. Helicobacter pylori: A Brief History of a Still Lacking Vaccine. Diseases 2014; 2(2): 187 doi: 10.3390/diseases2020187
|
| 64 |
Shen-Shong Chang, Hsiao-Yun Hu. <italic>Helicobacter pylori</italic>: Effect of coexisting diseases and update on treatment regimens. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 127-136 doi: 10.4292/wjgpt.v6.i4.127
|
| 65 |
Fansen Meng, Hongjin Tao, Yan Mi, Tianyu Yang, Xuanping Wang, Yuyo Go, Yunjuan Lin, Gangshi Wang. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pylori. Cancer Nanotechnology 2022; 13(1) doi: 10.1186/s12645-022-00121-2
|
| 66 |
Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo, Enzo Ierardi. Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical note. World Journal of Gastroenterology 2016; 22(38): 8638-8640 doi: 10.3748/wjg.v22.i38.8638
|
| 67 |
Qin Ma, Hancong Li, Jing Liao, Zhaolun Cai, Bo Zhang. Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.908202
|
| 68 |
Giuseppe Losurdo, Floriana Giorgio, Maria Pricci, Bruna Girardi, Francesco Russo, Giuseppe Riezzo, Manuela Martulli, Mariano Piazzolla, Francesco Cocomazzi, Francesco Abbruzzi, Elisabetta Parente, Rosa Paolillo, Alessia Mileti, Andrea Iannone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy. Antibiotics 2020; 9(10): 723 doi: 10.3390/antibiotics9100723
|
| 69 |
Halil Rakici, Teslime Ayaz, Remzi Adnan Akdogan, Recep Bedir. Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy. Digestion 2014; 90(4): 261 doi: 10.1159/000369788
|
| 70 |
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. Infection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
|
| 71 |
Andrea Iannone, Floriana Giorgio, Francesco Russo, Giuseppe Riezzo, Bruna Girardi, Maria Pricci, Suetonia C Palmer, Michele Barone, Mariabeatrice Principi, Giovanni FM Strippoli, Alfredo Di Leo, Enzo Ierardi. New fecal test for non-invasive <i>Helicobacter pylori</i> detection: A diagnostic accuracy study. World Journal of Gastroenterology 2018; 24(27): 3021-3029 doi: 10.3748/wjg.v24.i27.3021
|
| 72 |
Hideki Mori, Hidekazu Suzuki, Juntaro Matsuzaki, Hitoshi Tsugawa, Seiichiro Fukuhara, Sawako Miyoshi, Kenro Hirata, Takashi Seino, Misako Matsushita, Tatsuhiro Masaoka, Takanori Kanai. Efficacy of 10‐day Sitafloxacin‐Containing Third‐Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation. Helicobacter 2016; 21(4): 286 doi: 10.1111/hel.12286
|
| 73 |
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik. Current Status of the Third-LineHelicobacter pyloriEradication. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6523653
|